tirzepatide and osteoporosis does cause Tirzepatide, a dual GLP-1 GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites Does Tirzepatide Cause Osteoporosis? Evidence – Popular weight loss drugs have

That said, no study has directly tested this three-way combination

This includes tracking blood sugar levels to ensure they stay within a healthy range, as fluctuations could indicate the need to adjust the dosage or other aspects of ones lifestyle

If youre worried about missing a dose and having trouble calculating days with the time change, ask your provider ahead of your trip what they recommend

Its important to talk to your doctor about any concerns

Consider skipping your berberine dose on the day you inject early and the following day to reduce the combined effect

On Thursday, Eli Lilly, the maker of tirzepatide, issued a warning to the public